Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.
Clinical trial NCT04293172 · WITHDRAWN
Trial details
- NCT number
- NCT04293172
- Sponsor
- AstraZeneca
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2022-10-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.